Literature DB >> 16990514

Control of peripheral nerve myelination by the beta-secretase BACE1.

Michael Willem1, Alistair N Garratt, Bozidar Novak, Martin Citron, Steve Kaufmann, Andrea Rittger, Bart DeStrooper, Paul Saftig, Carmen Birchmeier, Christian Haass.   

Abstract

Although BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is essential for the generation of amyloid-b peptide in Alzheimer's disease, its physiological function is unclear. We found that very high levels of BACE1 were expressed at time points when peripheral nerves become myelinated. Deficiency of BACE1 resulted in the accumulation of unprocessed neuregulin 1 (NRG1), an axonally expressed factor required for glial cell development and myelination. BACE1-/- mice displayed hypomyelination of peripheral nerves and aberrant axonal segregation of small-diameter afferent fibers, very similar to that seen in mice with mutations in type III NRG1 or Schwann cell-specific ErbB2 knockouts. Thus, BACE1 is required for myelination and correct bundling of axons by Schwann cells, probably through processing of type III NRG1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990514     DOI: 10.1126/science.1132341

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  295 in total

1.  Prostaglandin D2 synthase/GPR44: a signaling axis in PNS myelination.

Authors:  Amelia Trimarco; Maria Grazia Forese; Valentina Alfieri; Alessandra Lucente; Paola Brambilla; Giorgia Dina; Damiana Pieragostino; Paolo Sacchetta; Yoshihiro Urade; Brigitte Boizet-Bonhoure; Filippo Martinelli Boneschi; Angelo Quattrini; Carla Taveggia
Journal:  Nat Neurosci       Date:  2014-11-02       Impact factor: 24.884

2.  BACE2 expression increases in human neurodegenerative disease.

Authors:  Christopher J Holler; Robin L Webb; Ashley L Laux; Tina L Beckett; Dana M Niedowicz; Rachel R Ahmed; Yinxing Liu; Christopher R Simmons; Amy L S Dowling; Angela Spinelli; Moshe Khurgel; Steven Estus; Elizabeth Head; Louis B Hersh; M Paul Murphy
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 3.  Alzheimer's therapeutics: translation of preclinical science to clinical drug development.

Authors:  Alena V Savonenko; Tatiana Melnikova; Andrew Hiatt; Tong Li; Paul F Worley; Juan C Troncoso; Phil C Wong; Don L Price
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 4.  Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin.

Authors:  Johannes Prox; Andrea Rittger; Paul Saftig
Journal:  Exp Brain Res       Date:  2011-11-27       Impact factor: 1.972

Review 5.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

Review 6.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

7.  Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.

Authors:  Kulandaivelu S Vetrivel; Xavier Meckler; Ying Chen; Phuong D Nguyen; Nabil G Seidah; Robert Vassar; Philip C Wong; Masaki Fukata; Maria Z Kounnas; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

8.  A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblasts.

Authors:  Tapan K Khan; Thomas J Nelson; Vishal A Verma; Paul A Wender; Daniel L Alkon
Journal:  Neurobiol Dis       Date:  2009-02-20       Impact factor: 5.996

9.  BACE1 regulates voltage-gated sodium channels and neuronal activity.

Authors:  Doo Yeon Kim; Bryce W Carey; Haibin Wang; Laura A M Ingano; Alexander M Binshtok; Mary H Wertz; Warren H Pettingell; Ping He; Virginia M-Y Lee; Clifford J Woolf; Dora M Kovacs
Journal:  Nat Cell Biol       Date:  2007-06-18       Impact factor: 28.824

10.  Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice.

Authors:  Xiaoyang Luo; Wanxia He; Xiangyou Hu; Riqiang Yan
Journal:  Biol Psychiatry       Date:  2013-10-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.